Boehringer Ingelheim, a leading research-driven biopharmaceutical company, today announced a further expansion and upgrade of its plant in Koropi, Greece. With an investment of EUR 120 million, the company will increase the manufacturing capacity of
A liquid compression system prototype at General Fusion’s Canadian labs RICHMOND, British Columbia, Jan. 11, 2024 (GLOBE NEWSWIRE) — General Fusion has published new, peer-reviewed scientific results that validate the company has achieved the smooth,
REGENETEN Patch 2024 First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces standout results for its REGENETEN Bioinductive Implant
Quantexa to provide category-leading AI-enabled technology, training, and industry expertise to ATII to improve how data is used in the identification and investigation of human trafficking NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) — Today,
Argentina’s Central Securities Depository (CSD) has successfully launched its new technology platform Rapidly accelerated launch timetable secures the platform’s ability to meet significant increase in volumes BUENOS AIRES, Argentina and NEW YORK, Jan. 11, 2024